top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
PAC1021
Pancreatic cancer tissue array contains 86 cases of malignant tumors, 10 cases of benign tumors, 5 cases of normal tissues, and 1 case inflammatory pancreatic tissue with grading and TNM staging data.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$374
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Pancreas carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
Tis - Carcinoma in situ
T1 - Tumor limited to pancreas, 2 cm or less in greatest dimension
T2 - Tumor limited to pancreas, more than 2 cm in greatest dimension
T3 - Tumor extends directly into any of the following: duodenum, bile duct, peripancreatic tissue
T4 - Tumor extends directly into any of the following: stomach, spleen, colon, adjacent large vessels
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
N1a - metastasis in a single regional lymph node
N1b - Metastasis in multiple regional lymph nodes
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
102
102
1.5mm
4um
8
13
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in pancreas cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 31 | Pancreas | Normal | |||
A02 | F | 63 | Pancreas | Normal | |||
A03 | F | 59 | Pancreas | Normal | |||
A04 | M | 35 | Pancreas | Normal | |||
A05 | M | 44 | Pancreas | Normal | |||
A06 | M | 36 | Pancreas | Chronic inflammation | |||
A07 | F | 39 | Pancreas | Paraganglioma | |||
A08 | F | 47 | Pancreas | Mucinous cystadenoma | |||
A09 | F | 56 | Pancreas | Serous cystadenoma | |||
A10 | F | 76 | Pancreas | Gastrointestinal stromal tumor, GIST | |||
A11 | F | 45 | Pancreas | Hemangioma | |||
A12 | M | 30 | Pancreas | Islet cell tumor | |||
A13 | M | 54 | Pancreas | Islet cell tumor | |||
B01 | M | 42 | Pancreas | Islet cell tumor | |||
B02 | F | 45 | Pancreas | Neuroendocrine carcinoma | T2N0M0 | ||
B03 | F | 28 | Pancreas | Islet cell tumor | |||
B04 | F | 20 | Pancreas | Neuroendocrine carcinoma | T2N0M0 | ||
B05 | M | 30 | Pancreas | Mixed acinar-endocrine carcinoma | T2N0M0 | ||
B06 | F | 60 | Pancreas | Neuroendocrine carcinoma | T3N1M0 | ||
B07 | F | 40 | Pancreas | Neuroendocrine carcinoma | T2N0M0 | ||
B08 | F | 59 | Pancreas | Islet cell tumor | |||
B09 | M | 56 | Pancreas | Islet cell tumor | |||
B10 | M | 59 | Pancreas | Neuroendocrine carcinoma | I | T2N1M0 | |
B11 | F | 36 | Pancreas | Mixed acinar-endocrine carcinoma | T2N0M0 | ||
B12 | F | 52 | Pancreas | Papillary carcinoma | T2N0M0 | ||
B13 | F | 21 | Pancreas | Solid-pseudopapillary tumor | I | T2N0M0 | |
C01 | F | 37 | Pancreas | Solid-pseudopapillary tumor | I | T4N1M0 | |
C02 | M | 39 | Pancreas | Serous cystadenocarcinoma | T4N0M0 | ||
C03 | M | 51 | Pancreas | Mucinous cystadenocarcinoma | T2N0M0 | ||
C04 | F | 61 | Pancreas | Mucinous cystadenocarcinoma | T2N0M0 | ||
C05 | F | 65 | Pancreas | Ductal adenocarcinoma | I | T3N0M0 | |
C06 | M | 43 | Pancreas | Ductal adenocarcinoma | I | T2N0M0 | |
C07 | M | 55 | Pancreas | Ductal adenocarcinoma | I | T4N0M0 | |
C08 | M | 80 | Pancreas | Ductal adenocarcinoma | I | T4N1M0 | |
C09 | F | 57 | Pancreas | Ductal adenocarcinoma | I | T2N0M0 | |
C10 | M | 64 | Pancreas | Ductal adenocarcinoma | I | T2N0M0 | |
C11 | F | 77 | Pancreas | Ductal adenocarcinoma | I | T2N0M0 | |
C12 | F | 44 | Pancreas | Ductal adenocarcinoma | I | T3N0M0 | |
C13 | M | 63 | Pancreas | Ductal adenocarcinoma | I | ||
D01 | F | 19 | Pancreas | Acinar cell carcinoma | I~II | T2N0M0 | |
D02 | M | 63 | Pancreas | Ductal adenocarcinoma | I~II | T3N1M0 | |
D03 | M | 46 | Pancreas | Ductal adenocarcinoma | I~II | T3N0M0 | |
D04 | M | 42 | Pancreas | Ductal adenocarcinoma | I~II | T4N0M0 | |
D05 | M | 63 | Pancreas | Ductal adenocarcinoma | I~II | T3N0M0 | |
D06 | M | 56 | Pancreas | Ductal adenocarcinoma | I~II | T3N0M0 | |
D07 | F | 57 | Pancreas | Ductal adenocarcinoma | I~II | T2N1M0 | |
D08 | F | 49 | Pancreas | Ductal adenocarcinoma | II | T3N1M1 | |
D09 | M | 40 | Pancreas | Ductal adenocarcinoma | II~III | T3N1M0 | |
D10 | F | 40 | Pancreas | Ductal adenocarcinoma | II | T4N0M1 | |
D11 | F | 60 | Pancreas | Ductal adenocarcinoma | II~III | T3N1M1 | |
D12 | M | 65 | Pancreas | Ductal adenocarcinoma | II | T4N0M0 | |
D13 | F | 58 | Pancreas | Ductal adenocarcinoma | II | T4N0M0 | |
E01 | M | 58 | Pancreas | Ductal adenocarcinoma | II | T3N0M0 | |
E02 | M | 62 | Pancreas | Ductal adenocarcinoma | II | T3N1M0 | |
E03 | M | 65 | Pancreas | Ductal adenocarcinoma | II | T2N0M0 | |
E04 | M | 84 | Pancreas | Ductal adenocarcinoma | II | T4N0M0 | |
E05 | F | 45 | Pancreas | Ductal adenocarcinoma | II | T3N0M0 | |
E06 | M | 60 | Pancreas | Ductal adenocarcinoma | II | T2N0M0 | |
E07 | F | 64 | Pancreas | Ductal adenocarcinoma | II | T3N1M0 | |
E08 | F | 62 | Pancreas | Ductal adenocarcinoma | II | T2N1M0 | |
E09 | F | 55 | Pancreas | Ductal adenocarcinoma | II | T3N1M0 | |
E10 | M | 62 | Pancreas | Mucinous adenocarcinoma | II | T3N1M1 | |
E11 | M | 67 | Pancreas | Ductal adenocarcinoma | II | T2N0M0 | |
E12 | M | 62 | Pancreas | Ductal adenocarcinoma | II | ||
E13 | M | 50 | Pancreas | Ductal adenocarcinoma | II | T3N0M1 | |
F01 | F | 28 | Pancreas | Ductal adenocarcinoma | II | T3N0M1 | |
F02 | M | 68 | Pancreas | Ductal adenocarcinoma | II | T3N0M1 | |
F03 | M | 72 | Pancreas | Ductal adenocarcinoma | II | T3N0M1 | |
F04 | F | 70 | Pancreas | Ductal adenocarcinoma | II | T3N0M1 | |
F05 | F | 63 | Pancreas | Ductal adenocarcinoma | II | ||
F06 | M | 76 | Pancreas | Ductal adenocarcinoma | II | T2N0M0 | |
F07 | M | 73 | Pancreas | Ductal adenocarcinoma | II | T4N0M1 | |
F08 | F | 58 | Pancreas | Ductal adenocarcinoma | II | ||
F09 | M | 69 | Pancreas | Ductal adenocarcinoma | II | ||
F10 | M | 63 | Pancreas | Ductal adenocarcinoma | II | ||
F11 | F | 75 | Pancreas | Ductal adenocarcinoma | II~III | T2N1M0 | |
F12 | M | 56 | Pancreas | Ductal adenocarcinoma | II~III | T2N0M0 | |
F13 | M | 73 | Pancreas | Ductal adenocarcinoma | II~III | T3N0M0 | |
G01 | M | 40 | Pancreas | Ductal adenocarcinoma | II~III | T3N1M0 | |
G02 | M | 65 | Pancreas | Ductal adenocarcinoma | II~III | T2N1M0 | |
G03 | F | 68 | Pancreas | Ductal adenocarcinoma | II~III | T3N1M0 | |
G04 | F | 59 | Pancreas | Ductal adenocarcinoma | II~III | T3N0M1 | |
G05 | F | 50 | Pancreas | Ductal adenocarcinoma | II-III | T2N0M0 | |
G06 | F | 71 | Pancreas | Ductal adenocarcinoma | II-III | ||
G07 | M | 69 | Pancreas | Ductal adenocarcinoma | II-III | T3N0M1 | |
G08 | M | 55 | Pancreas | Ductal adenocarcinoma | II-III | ||
G09 | M | 51 | Pancreas | Ductal adenocarcinoma | III | T2N0M0 | |
G10 | M | 70 | Pancreas | Ductal adenocarcinoma | III | T3N1M0 | |
G11 | M | 53 | Pancreas | Ductal adenocarcinoma | III | T2N0M0 | |
G12 | F | 64 | Pancreas | Ductal adenocarcinoma | III | T2N0M0 | |
H01 | F | 66 | Pancreas | Ductal adenocarcinoma | III | T4N1M0 | |
H02 | F | 52 | Pancreas | Ductal adenocarcinoma | III | T4N0M0 | |
H03 | F | 65 | Pancreas | Ductal adenocarcinoma | III | T2N0M0 | |
H04 | F | 38 | Pancreas | Ductal adenocarcinoma | III | T3N1M0 | |
H05 | F | 57 | Pancreas | Ductal adenocarcinoma | III | T3N1M0 | |
H06 | F | 57 | Pancreas | Metastatic stomach adenocarcinoma | III | ||
H07 | M | 61 | Pancreas | Ductal adenocarcinoma | III | T3N0M0 | |
H08 | M | 72 | Pancreas | Ductal adenocarcinoma | III | T3N0M1 | |
H09 | M | 45 | Pancreas | Ductal adenocarcinoma | III | T3N0M1 | |
H10 | M | 48 | Pancreas | Ductal adenocarcinoma | III | ||
H11 | M | 58 | Pancreas | Undifferentiated carcinoma | IV | T2N0M0 | |
H12 | F | 74 | Pancreas | Undifferentiated carcinoma | IV | T4N1M0 | |
null |
bottom of page